Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 652 of 1,261
  1. US 9556144

    Compound as WNT signaling inhibitor, composition, and use thereof

    Curegenix, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  2. US 9555064

    Protease-deficient Bacillus anthracis

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  3. US 9555017

    Methods of making a mixture of salts of gamma-hydroxybutyrate

    Jazz Pharmaceuticals Ireland Limited · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  4. US 9555037

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  5. WO 2017013210

    TRAITEMENT ET PRÉVENTION DE MALADIES VIRALES AVEC DES COMPOSÉS DE 2,3-DIHYDROBENZOFURAN-5-YL

    4SC AG [DE] · Granted Jan 26, 2017 · Expires Jan 21, 2037

    granted
  6. US 2017020867

    USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASE

    AB SCIENCE [FR] · Granted Jan 26, 2017 · Expires Jan 21, 2037

    granted
  7. US 9549995

    Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

    The Board of Regents of the University of Texas System · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  8. US 9549905

    Treatment of inflammatory and infectious skin disorders

    The Regents of the University of California · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  9. US 9549954

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  10. US 9550974

    Derivation of embryonic stem cells

    Astellas Institute for Regenerative Medicine · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  11. US 9550756

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  12. US 9551713

    Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer

    The Board of Regents of the University of Texas System · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  13. US 9550818

    Methods for use of vascular endothelial growth factor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  14. US 9550078

    EDAR ligand derived peptides and use thereof

    CAREGEN CO., LTD. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  15. US 9550002

    Phospholipid analogs as diapeutic agents and methods thereof

    CELLECTAR BIOSCIENCES, INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  16. US 9549943

    A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

    CAN-FITE BIOPHARMA LTD. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  17. US 9549940

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  18. US 9549913

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  19. US 9551721

    Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases

    The Board of Regents of the University of Texas System · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  20. US 9551722

    Amyloid binding agents

    The Regents of the University of California · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  21. US 9550775

    Substituted triazolopyridines and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  22. US 9550988

    Antisense compounds

    Ionis Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  23. US 9549975

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  24. US 9550837

    Therapeutic uses of anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.